After price deal, Takeda’s lung cancer drug Exkivity wins UK green light ahead of J&J rival
After price deal, Takeda’s lung cancer drug Exkivity wins UK [...]
As AstraZeneca sounds the slowdown alarm in China, Jefferies beats the drum for growing branded drug market
As AstraZeneca sounds the slowdown alarm in China, Jefferies beats [...]
Wockhardt, Serum Institute of India to build UK fill-finish plant in Wales
Wockhardt, Serum Institute of India to build UK fill-finish plant [...]
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first drug for rare genetic epileptic condition
Marinus Pharmaceuticals scores an FDA nod for Ztalmy, the first [...]
Pfizer CEO scored big raise—to $24M—as drugmaker played a leading role in pandemic fight
Pfizer CEO scored big raise—to $24M—as drugmaker played a leading [...]
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna files a more ambitious FDA submission
After Pfizer’s pitch for 2nd round of COVID boosters, Moderna [...]
As HAE offerings from Takeda and BioCryst gain steam, a doc survey offers lessons for the long term: analyst
As HAE offerings from Takeda and BioCryst gain steam, a [...]
Pfizer’s deal with Medicines Patent Pool includes 35 companies from 12 countries to produce generic Paxlovid
Pfizer’s deal with Medicines Patent Pool includes 35 companies from [...]
Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting risks; Zai Lab’s new COO from Lilly
Fierce Pharma Asia—Eisai’s reduced Aduhelm role; Chinese biotechs’ US delisting [...]
Pharma’s ‘superhero’ image fades as inflation, Ukraine drown out the industry
Pharma’s ‘superhero’ image fades as inflation, Ukraine drown out the [...]